Loading…
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
THE immunosuppressive drugs cyclosporin A (CsA) and FKS06 both interfere with a Ca 2+ -sensitive T-cell signal transduction pathway 1–4 thereby preventing the activation of specific transcription factors (such as NF-AT and NF-IL2A) 1,5–7 involved in lymphokine gene expression. CsA and FK506 seem to...
Saved in:
Published in: | Nature (London) 1992-06, Vol.357 (6380), p.695-697 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | THE immunosuppressive drugs cyclosporin A (CsA) and FKS06 both interfere with a Ca
2+
-sensitive T-cell signal transduction pathway
1–4
thereby preventing the activation of specific transcription factors (such as NF-AT and NF-IL2A)
1,5–7
involved in lymphokine gene expression. CsA and FK506 seem to act by interaction with their cognate intracellular receptors
8–10
, cyclophilin and FKBP, respectively (see ref. 11 for review). The Ca
2+
/calmodulin-regulated phosphatase calcineurin is a major target of drug-isomerase complexes
in vitro
12
We have therefore tested the hypothesis that this interaction is responsible for the
in vivo
effects of CsA/FK506. We report here that overexpression of calcineurin in Jurkat cells renders them more resistant to the effects of CsA and FK506 and augments both NFAT- and NFIL2A-dependent transcription. These results identify calcineurin as a key enzyme in the T-cell signal transduction cascade and provide biological evidence to support the notion that the interaction of drug-isomerase complexes with calcineurin underlies the molecular basis of CsA/FK506-mediated immunosuppression. |
---|---|
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/357695a0 |